MSR
NVO

Main Street Research’s Novo Nordisk NVO Stock Holding History

Main Street Research’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,338
Closed -$800K – 125
2025
Q1 		$800K Sell
11,338
-74,465
-87% -$6.15M 0.05% 62
2024
Q4 		$7.38M Sell
85,803
-376,265
-81% -$40.7M 0.46% 35
2024
Q3 		$55M Buy
462,068
+981
+0.2% +$131K 3.46% 7
2024
Q2 		$65.8M Sell
461,087
-1,225
-0.3% -$162K 4.34% 3
2024
Q1 		$59.8M Sell
462,312
-4,534
-1% -$540K 4.06% 3
2023
Q4 		$48.3M Sell
466,846
-8,516
-2% -$842K 3.88% 4
2023
Q3 		$43.2M Sell
475,362
-8,906
-2% -$785K 4.45% 4
2023
Q2 		$39.2M Buy
484,268
+6,046
+1% +$494K 6.25% 4
2023
Q1 		$38.3M Sell
478,222
-4,388
-0.9% -$311K 7.57% 3
2022
Q4 		$32.7M Buy
482,610
+4,774
+1% +$280K 7.95% 4
2022
Q3 		$23.8M Buy
477,836
+9,600
+2% +$514K 5.24% 8
2022
Q2 		$26.1M Buy
468,236
+2,096
+0.4% +$116K 6.84% 6
2022
Q1 		$25.9M Buy
+466,140
New +$23.9M 2.43% 18

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Main Street Research's NVO Position: Q2 2025 in Review

Main Street Research sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 11,338 shares — an estimated $800K sold.

Main Street Research first reported a position in NVO in Q1 2022 and held it in 13 quarters. The position peaked at $65.8M in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Main Street Research reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Main Street Research sold 11,338 Novo Nordisk shares in Q2 2025, an estimated $800K.
  • Main Street Research first reported a position in Novo Nordisk in Q1 2022 and held it in 13 quarters.
  • Main Street Research's Novo Nordisk position peaked at $65.8M in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Main Street Research's 13F filing for Q2 2025, filed 5 Aug 2025.